Abstract
We examined whether survivin acts as a constitutive and inducible radioresistance factor in pancreatic cancer cells. Using a quantitative TaqMan reverse transcription‐polymerase chain reaction for survivin mRNA in five pancreatic cancer cell lines, we found an inverse relationship between survivin mRNA expression and radiosensitivity. PANC‐1 cells, which had the highest survivin mRNA levels, were most resistant to X‐irradiation; MIAPaCa‐2 cells, which showed the least survivin mRNA expression, were the most sensitive to X‐irradiation. Our results suggested that survivin could act as a constitutive radioresistance factor in pancreatic cancer cells. To determine whether radioresistance is enhanced by induction of survivin expression by irradiation, PANC‐1 and MIAPaCa‐2 cells were subjected to sublethal doses of X‐irradiation followed by a lethal dose. Survivin mRNA expression was increased significantly in both PANC‐1 and MIAPaCa‐2 cell lines by pretreatment with a sublethal dose of X‐irradiation, as was cell survival after exposure to the lethal dose. In this system, enzymatic caspase‐3 activity was significantly suppressed in cells with acquired resistance. These results suggest that survivin also acts as an inducible radioresistance factor in pancreatic cancer cells. Survivin, then, appears to enhance radioresistance in pancreatic cancer cells; inhibition of survivin mRNA expression may improve the effectiveness of radiotherapy.
Keywords: Survivin, Pancreatic cancer cell lines, X‐irradiation, Radioresistance
Full Text
The Full Text of this article is available as a PDF (79.1 KB).
REFERENCES
- 1. ) Inanami , O. , Takahashi , K. and Kuwabara , M.Attenuation of caspase‐3‐dependent apoptosis by Trolox post‐treatment of X‐irradiated MOLT‐4 cells . Int. J. Radiat. Biol. , 75 , 115 – 163 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Fukunaga‐Johnson , N. , Ryan , J. J. , Wicha , M. , Nunez , G. and Clarke , M. F.Bcl‐2 protects murine erythroleukemia cells from p53‐dependent and ‐independent radiationinduced cell death . Carcinogenesis , 16 , 1761 – 1767 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Takahashi , K. , Inanami , O. and Kuwabara , M.Effects of intracellular calcium chelator BAPTA‐AM on radiationinduced apoptosis regulated by activation of SAPK/JNK and caspase‐3 in MOLT‐4 cells . Int. J. Radiat. Biol. , 75 , 1099 – 1105 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Jaattela , M.Escaping cell death: survival proteins in cancer . Exp. Cell Res. , 248 , 30 – 43 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Ambrosini , G. , Adida , C. and Altieri , D. C.A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma . Nat. Med. , 3 , 917 – 921 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 6. ) LaCasse , E. C. , Baird , S. , Korneluk , R. G. and MacKenzie , A. E.The inhibitors of apoptosis (IAPs) and their emerging role in cancer . Oncogene , 17 , 3247 – 3259 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Kobayashi , K. , Hatano , M. , Otaki , M. , Ogasawara , T. and Tokuhisa , T.Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation . Proc. Natl. Acad. Sci. USA , 96 , 1457 – 1462 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. ) Li , F. , Ambrosini , G. , Chu , E. Y. , Plescia , J. , Tognin , S. , Marchisio , P. C. and Altieri , D. C.Control of apoptosis and mitotic spindle checkpoint by survivin . Nature , 396 , 580 – 584 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Li , F. , Ackermann , E. J. , Bennett , C. F. , Rothermel , A. L. , Plescia , J. , Tognin , S. , Villa , A. , Marchisio , P. C. and Altieri , D. C.Pleiotropic cell‐division defects and apoptosis induced by interference with survivin function . Nat. Cell Biol. , 1 , 461 – 466 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Tamm , I. , Wang , Y. , Sausville , E. , Scudiero , D. A. , Vigna , N. , Oltersdorf , T. and Reed , J. C.IAP‐family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs . Cancer Res. , 58 , 5315 – 5320 ( 1998. ). [PubMed] [Google Scholar]
- 11. ) Adida , C. , Berrebi , D. , Peuchmaur , M. , Reyes‐Mugica , M. and Altieri , D. C.Anti‐apoptosis gene, survivin, and prognosis of neuroblastoma . Lancet , 351 , 882 – 883 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Ambrosini , G. , Adida , C. , Sirugo , G. and Altieri , D. C.Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting . J. Biol. Chem. , 273 , 11177 – 11182 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Kawasaki , H. , Altieri , D. C. , Lu , C. D. , Toyoda , M. , Tenjo , T. and Tanigawa , N.Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer . Cancer Res. , 58 , 5071 – 5074 ( 1998. ). [PubMed] [Google Scholar]
- 14. ) Lu , C. D. , Altieri , D. C. and Tanigawa , N.Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas . Cancer Res. , 58 , 1808 – 1812 ( 1998. ). [PubMed] [Google Scholar]
- 15. ) Swana , H. S. , Grossman , D. , Anthony , J. N. , Weiss , R. M. and Altieri , D. C.Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer . N. Engl. J. Med. , 341 , 452 – 453 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Yajima , T. , Yagihashi , A. , Kameshima , H. , Kobayashi , D. , Furuya , D. , Hirata , K. and Watanabe , N.Quantitative reverse transcription‐PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system . Clin. Chem. , 44 , 2441 – 2445 ( 1998. ). [PubMed] [Google Scholar]
- 17. ) Yajima , T. , Yagihashi , A. , Kameshima , H. , Furuya , D. , Kobayashi , D. , Hirata , K. and Watanabe , N.Establishment of quantitative reverse transcription‐polymerase chain reaction assays for human telomerase‐associated genes . Clin. Chim. Acta , 290 , 117 – 127 ( 2000. ). [DOI] [PubMed] [Google Scholar]
- 18. ) Tsuji , Y. , Watanabe , N. , Okamoto , T. , Tsuji , N. , Sasaki , H. , Akiyama , S. , Yamauchi , N. and Niitsu , Y.Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity . Cancer Res. , 52 , 6258 – 6262 ( 1992. ). [PubMed] [Google Scholar]
- 19. ) Watanabe , N. , Tsuji , N. , Tsuji , Y. , Sasaki , H. , Okamoto , T. , Akiyama , S. , Kobayashi , D. , Sato , T. , Yamauchi , N. and Niitsu , Y.Endogenous tumor necrosis factor inhibits the cytotoxicity of exogenous tumor necrosis factor and adriamycin in pancreatic carcinoma cells . Pancreas , 13 , 395 – 400 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 20. ) Watanabe , N. , Tsuji , N. , Kobayashi , D. , Yamauchi , N. , Akiyama , S. , Sasaki , H. , Sato , T. , Okamoto , T. and Niitsu , Y.Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity in pancreatic carcinoma cells via enhancement of the heat shock elementbinding activity of heat shock factor 1 . Chemotherapy , 43 , 406 – 414 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Maeda , M. , Watanabe , N. , Okamoto , T. , Tsuji , N. and Niitsu , Y.Endogenous tumor necrosis factor functions as a resistant factor against adriamycin . Int. J. Cancer , 58 , 376 – 379 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 22. ) Watanabe , N. , Okamoto , T. , Tsuji , N. , Sasaki , H. , Akiyama , S. , Kobayashi , D. , Sato , T. , Yamauchi , N. and Niitsu , Y.Reversal of tumor necrosis factor resistance in tumor cells by adriamycin via suppression of intracellular resistance factors . Jpn. J. Cancer Res. , 86 , 395 – 399 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]